Clinical Trials Browser

zimberelimab × Breast × 90 days × Clear all

Squamous Cell Carcinoma of Head and Neck, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Ovarian Neoplasms, Stomach Neoplasms, Triple Negative Breast Neoplasms

NCT07134556 2026-01-23

ADJUNCT

Phase 2 Not yet recruiting

25 enrolled

Breast

Triple Negative Breast Neoplasms

Clinical Trials

ARC-25

ADJUNCT